arrow
Y

Yoichi Nakanishi

kitakyushu city hospital organization
H指数:61
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term survival outcomes associated with inhalation therapy in chronic obstructive pulmonary disease: a 5-year multicenter prospective cohort study

慢性阻塞性肺疾病患者吸入疗法相关的长期生存结局:一项为期5年的多中心前瞻性队列研究

2026-03-240
OAAI
Diagnostic utility of high-mobility group box 1 for acute exacerbations of idiopathic pulmonary fibrosis

高迁移率族蛋白1对特发性肺纤维化急性加重的诊断效用

2025-11-050
OAAI
Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias

特发性间质性肺炎患者肌肉质量的预后影响:特发性肺纤维化及其他特发性间质性肺炎的分析

2025-10-150
OAAI
Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry
2023-11-1410
OAAI
Five-year follow up analysis of Japanese ILD registry
2023-10-270
PRE
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer
2022-12-149
PRE
Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment
2022-11-011
OAAI
A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
2022-05-0618
OAAI
Pulse oximetry is an essential tool that saves lives: a call for standardisation
2021-06-040
OA
Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer
2021-06-0116
OAAI
Clinical impact of probiotics on the efficacy of anti-PD-1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weighting
2021-03-2655
OAAI